Possibilities of medical relaxation of the internal anal sphincter for anal fissures

An anal fissure is a longitudinal tear defect in the skin of the anal canal distal to the dentate line. Anal fissure is a socially significant disease that worsens the quality of life of patients. The spasm of the internal sphincter is a guiding pathogenetic mechanism in the development of chronic anal fissures. It leads to circulatory disorder in the anoderm and non-healing wounds. Treatment of chronic anal fissure, as a rule, is based on a decrease in the tone of the internal anal sphincter and in the modern arsenal of coloproctologists there are both surgical and pharmacological ways to eliminate spasm. Lateral internal sphincterotomy is still the gold standard for the definitive treatment of anal fissure, but anal incontinence is a serious complication of the procedure. This article presents an overview of the available modern means for drug relaxation of the internal anal sphincter and the authors' experience in using the first fixed-dose combination of 0.3% nifedipine and 2.0% lidocaine topical gel authorized for use in Russia in patients with the chief complaint of pain during and after a bowel movement that requires the use of analgesics. A spontaneous wave activity in the resting phase, which indicated the presence of anal sphincter spasm, was recorded in all patients. According to our observation, the complete healing of the anal fissure and the anal sphincter relaxation was instrumentally confirmed in 70% of patients.

1. Shelygin Yu.A., Blagodarny L.A. Handbook of Coloproctology. Moscow: Littera; 2012. 596 p. (In Russ.).

2. Odaryuk T.S., Vorobiev G.I., Shelygin Yu.A. Rectal cancer surgery: atlas. Moscow: Dedalus; 2005. 254 p. (In Russ.).

3. Militarev Yu.M., Vrublevsky V.A. Prevalence of diseases of the rectum and colon in the adult population of Moscow. Problemy proktologii = Proctology Problems. 1983;(4):6–10. (In Russ.).

4. Wienert V., Raulf F., Mlitz H. Anal Fissure Disease: Prevention and Quality of Life. In: Anal Fissure: Symptoms, Diagnosis and Therapies. Springer, Cham; 2017, pp. 75–77. https://doi.org/10.1007/978-3-319-49244-5_7.

5. Luri-Prieto P., Candela-Gomis A., Palazón-Bru A., NavarroCremades F., Gil-Guillén V.F., Compañ-Rosique A.F. Impact of Anal Fissure on Neuroticism, Extraversion, Openness to Experience, Agreeableness, and Conscientiousness: A CaseControl Study. Visc Med. 2021;37(2):128–133. https://doi.org/10.1159/000507382.

6. Navarro-Sánchez A., Luri-Prieto P., Compañ-Rosique A., Navarro-Ortiz R., Berenguer-Soler M., Gil-Guillén V.F. et al. Sexuality, Quality of Life, Anxiety, Depression, and Anger in Patients with Anal Fissure. A Case-Control Study. J Clin Med. 2021;10(19):4401. https://doi.org/10.3390/jcm10194401.

7. Hall G., Kann B.R. Anal Fissure. In: Zutshi M. (ed.). Anorectal Disease: Contemporary Management. Springer, Cham; 2016, pp. 95–126. https://doi.org/10.1007/978-3-319-23147-1_5.

8. Lund J.N., Scholefield J.H. Aetiology and treatment of anal fissure. Br J Surg. 1996;83(10):1335–1344. https://doi.org/10.1002/bjs.1800831006.

9. Agapov M.A., Aliev F.Sh., Biryukov O.M., Blagodarny L.A., Vasiliev S.V., Grigoriev E.G. et al. Anal fissure: clinical guidelines. Moscow; 2021. (In Russ.) Available at: https://legalacts.ru/doc/klinicheskie-rekomendatsii-analnajatreshchina-utv-minzdravom-rossii/.

10. Jonas M., Scholefield J.H. Anal Fissure. Gastroenterol Clin North Am. 2001;30(1):167–181. https://doi.org/10.1016/s0889-8553(05)70172-2.

11. Van Outryve M. Physiopathology of the anal fissure. Acta Chir Belg. 2006;106(5):517–518. https://doi.org/10.1080/00015458.2006.11679942.

12. Yiannakopoulou E. Botulinum toxin and anal fissure: efficacy and safety systematic review. Int J Colorectal Dis. 2012;27(1):1–9. https://doi.org/10.1007/s00384-011-1286-5.

13. Altomare D.F., Rinaldi M., Milito G., Arcanà F., Spinelli F., Nardelli N. et al. Glyceryl trinitrate for chronic anal fissure – healing or headache? Results of a multicenter, randomized, placebo-controled, double-blind trial. Dis Colon Rectum. 2000;43(2):174–179. https://doi.org/10.1007/BF02236977.

14. Nelson R.L., Thomas K., Morgan J., Jones A. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2012;2012(2):CD003431. https://doi.org/10.1002/14651858.CD003431.pub3.

15. Khan M.S., Akbar I., Zeb J., Ahmad S., Khan A. Outcome of 0.2% Glyceryltrinitrate Cream Versus 2% Diltiazem Cream in the Treatment of Chronic Anal Fissure. J Ayub Med Coll Abbottabad. 2017;29(2):280–284. Available at: https://jamc.ayubmed.edu.pk/jamc/index.php/jamc/article/view/1382/969.

16. Katsinelos P., Papaziogas B., KoutelidakisI., Paroutoglou G., Dimiropoulos S., Souparis A., Atmatzidis K. Topical 0.5% nifedipine vs. lateral internal sphincterotomy for the treatment of chronic anal fissure: long-term follow-up. Int J Colorectal Dis. 2006;21(2):179–183. https://doi.org/10.1007/s00384-005-0766-x.

17. Seliverstov D.V., Getman M.A., Manuilov D.M., Khubezov D.A., Kuznetsov A.V., Yudin V.A. et al. The efficacy and safety of the new drug Fissario in clinical usage for the topical treatment of the acute anal fissure associated with chronic hemorrhoid disease. Koloproktologia = Coloproctology. 2017;(3):45–51. (In Russ.) https://doi.org/10.33878/2073-7556-2017-0-3-45-51.